Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland M Schaefer

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Biochemical and Biophysical Research Communications|October 7, 2004
Nephrin expression is increased in anti-Thy1.1-induced glomerulonephritis in ratsLiliana Schaefer, Shuyu Ren, Roland M Schaefer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stressMarkus Kosch, Andrea Levers, Manfred Fobker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapyRenzo Mignani, Sandro Feriozzi, Roland M Schaefer, et al.
AJR. American Journal of Roentgenology|January 5, 2002
Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysabilityBernd Tombach, Christoph Bremer, Peter Reimer, et al.
European Heart Journal|December 4, 2003
Haemoglobin-related mortality in patients undergoing percutaneous coronary interventionsHolger Reinecke, Torsten Trey, Jürgen Wellmann, et al.
BMJ Open|November 24, 2012
Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Munster Study (FaMuS) dataMarkus A Engelen, Eva Brand, Timo B Baumeister, et al.
Kidney International|August 26, 2004
Enzyme replacement therapy administered during hemodialysis in patients with Fabry diseaseMarkus Kosch, Hans-Georg Koch, Joao Paulo Oliveira, et al.
The Journal of Clinical Investigation|November 19, 2010
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritisKristin Moreth, Rebekka Brodbeck, Andrea Babelova, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2005
Nitric oxide upregulates induction of PDGF receptor-alpha expression in rat renal mesangial cells and in anti-Thy-1 glomerulonephritisKarl-Friedrich Beck, Gülmisal Güder, Liliana Schaefer, et al.
The American Journal of Pathology|January 4, 2007
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycinLiliana Schaefer, Wasiliki Tsalastra, Andrea Babelova, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biochemical and Biophysical Research Communications|October 7, 2004
Nephrin expression is increased in anti-Thy1.1-induced glomerulonephritis in ratsLiliana Schaefer, Shuyu Ren, Roland M Schaefer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stressMarkus Kosch, Andrea Levers, Manfred Fobker, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapyRenzo Mignani, Sandro Feriozzi, Roland M Schaefer, et al.
AJR. American Journal of Roentgenology|January 5, 2002
Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysabilityBernd Tombach, Christoph Bremer, Peter Reimer, et al.
European Heart Journal|December 4, 2003
Haemoglobin-related mortality in patients undergoing percutaneous coronary interventionsHolger Reinecke, Torsten Trey, Jürgen Wellmann, et al.
BMJ Open|November 24, 2012
Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Munster Study (FaMuS) dataMarkus A Engelen, Eva Brand, Timo B Baumeister, et al.
Kidney International|August 26, 2004
Enzyme replacement therapy administered during hemodialysis in patients with Fabry diseaseMarkus Kosch, Hans-Georg Koch, Joao Paulo Oliveira, et al.
The Journal of Clinical Investigation|November 19, 2010
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritisKristin Moreth, Rebekka Brodbeck, Andrea Babelova, et al.
Journal of the American Society of Nephrology : JASN|May 6, 2005
Nitric oxide upregulates induction of PDGF receptor-alpha expression in rat renal mesangial cells and in anti-Thy-1 glomerulonephritisKarl-Friedrich Beck, Gülmisal Güder, Liliana Schaefer, et al.
The American Journal of Pathology|January 4, 2007
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycinLiliana Schaefer, Wasiliki Tsalastra, Andrea Babelova, et al.
Pageof 4